ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, synthesis, and biological evaluation of N-(pyridin-3-yl) pyrimidin-4-amine analogues as novel cyclin-dependent kinase 2 inhibitors for cancer therapy

Zeng, Wen-Bin; Ji, Tang-Yang; Zhang, Yan-Ting; Ma, Yu-Feng; Li, Rou; You, Wen-Wei; Zhao, Pei- Liang*南方医科大学
Bioorganic Chemistry2024-2DOI: 10.1016/j.bioorg.2023.107019
1被引6阅读
引用收藏
分享

摘要

The discovery and development of CDK2 inhibitors has currently been validated as a hot topic in cancer therapy. Herein, a series of novel N-(pyridin-3-yl)pyrimidin-4-amine derivatives were designed and synthesized as potent CDK2 inhibitors. Among them, the most promising compound 7l presented a broad antiproliferative efficacy toward diverse cancer cells MV4-11, HT-29, MCF-7, and HeLa with IC50 values of 0.83, 2.12, 3.12, and 8.61 mu M, respectively, which were comparable to that of Palbociclib and AZD5438. Interestingly, these compounds were less toxic on normal embryonic kidney cells HEK293 with high selectivity index. Further mechanistic studies indicated 7l caused cell cycle arrest and apoptosis on HeLa cells in a concentration-dependent manner. Moreover, 7l manifested potent and similar CDK2/cyclin A2 nhibitory activity to AZD5438 with an IC50 of 64.42 nM. These findings revealed that 7l could serve as a highly promising scaffold for CDK2 inhibitors as potential anticancer agents and functional probes.

学科与关键词

关键词
N-(pyridin-3-yl)pyrimidin-4-amineAntiproliferative activityCDK2 inhibitor
相关
加载中…
  • Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity
    Li, Qiu; Chen, Lin; Ma, Yu-Feng; Jian, Xie-Er; Ji, Jia-Hao; You, Wen-Wei; Zhao, Pei-Liang*Bioorganic Chemistry, 2021, 116: 105324.被引 7
  • Design, synthesis and antiproliferative activity of novel 2,4-diamino-5--methyleneaminopyrimidine derivatives as potential anticancer agents
    Li, Qiu; Chen, Lin; Jian, Xie-Er; Lv, Dong-Xin; You, Wen-Wei; Zhao, Pei-Liang*Bioorganic and Medicinal Chemistry Letters, 2021, 47: 128213.被引 6
  • Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
    Xie, Zhouling; Hou, Shuzeng; Yang, Xiaoxiao; Duan, Yajun; Han, Jihong; Wang, Qin*; Liao, Chenzhong*Journal of Medicinal Chemistry, 2022, 65(9): 6356-6389.被引 21
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic Chemistry
发表日期
2024-02
卷期
第 143 卷
页码
107019
DOI
10.1016/j.bioorg.2023.107019
语言
ENGLISH
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou City, China [202201011796]; GuangDong Basic and Applied Basic Research Foundation [2023A1515011227]

作者

  • Z

    Zeng, Wen-Bin (第一作者)

    new · southern med univ

  • J

    Ji, Tang-Yang

    new · southern med univ

查看全部 7 位作者收起作者
  • Z

    Zhang, Yan-Ting

    new · southern med univ

  • M

    Ma, Yu-Feng

    new · southern med univ

  • L

    Li, Rou

    new · southern med univ

  • Y

    You, Wen-Wei

    new · southern med univ

  • Z

    Zhao, Pei- Liang (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417